Survey of thorotrast-associated liver cancers in Japan

Journal Article · Sat Jan 01 00:00:00 EST 1983 · JNCI, J. Natl. Cancer Inst.; (United States)

OSTI ID:6219743

Yamada, S; Hosoda, S; Tateno, H; Kido, C; Takahashi, S

Data on 93 autopsy cases (group A) of thorotrast-associated liver cancers were obtained from the Annual of Pathological Autopsy Cases in Japan from 1958 to 1979, and data on 78 autopsy cases (group B) of thorotrast-associated liver cancers were obtained from the Japanese literature from 1953 to 1980. Cholangiocarcinoma (CLC) constituted 58% of group A and 55% of group B. The curve of the cumulative numbers of patients with CLC versus year in group A was almost linear, showing an increasing risk per surviving patients with advancing time. Angiosarcoma (AGS) occurred in 25% of group A and 24% of group B. The number of patients with AGS increased significantly after 1969 in both groups (P less than 0.05). In group B, age and years after thorotrast injection of patients with AGS were statistically higher than those of patients with CLC (age: P less than 0.05; years after thorotrast injection: P less than 0.0001). Hepatocellular carcinoma (HPC) accounted for 17 and 21% of groups A and B, respectively. When yearly distribution, age, and time after thorotrast injection of patients with HPC were correlated with those of patients with other liver cancers, the only statistically significant difference between patients with HPC and patients with CLC (P less than 0.02) was in the years after thorotrast administration. Since 1977 multiple primary liver cancers including AGS developed in thorotrast-administered patients in both groups.

• Research Organization: Laboratory of Pathology, Aichi Cancer Center Research Institute, Tashiro-cho, Chikusa-ku, Japan
• OSTI ID: 6219743
• Journal Information: JNCI, J. Natl. Cancer Inst.; (United States), Vol. 70:1
• Country of Publication: United States
• Language: English

Related Subjects

63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
62 RADIOLOGY AND NUCLEAR MEDICINE
LIVER
BIOLOGICAL RADIATION EFFECTS
NEOPLASMS
RADIOINDUCTION
THOROTRAST
SIDE EFFECTS
EPIDEMIOLOGY
JAPAN
LATENCY PERIOD
PATHOLOGY
PATIENTS
RADIONUCLIDE ADMINISTRATION
RADIOTHERAPY
REGIONAL ANALYSIS
ACTINIDE COMPOUNDS
ASIA
BIOLOGICAL EFFECTS
BODY
CHALCOGENIDES
COLLOIDS
CONTRAST MEDIA
DIGESTIVE SYSTEM
DISEASES
DISPERSIONS
GLANDS
MEDICINE
NUCLEAR MEDICINE
ORGANS
OXIDES
OXYGEN COMPOUNDS
RADIATION EFFECTS
RADIOCOLLOIDS
RADIOLOGY
THERAPY
THORIUM COMPOUNDS
THORIUM OXIDES
560151* - Radiation Effects on Animals- Man
550601 - Medicine- Unsealed Radionuclides in Diagnostics